GLP-1 receptor agonists and fenofibrate medications significantly reduced the risk for developing diabetic macular edema, according to a study published in Ophthalmology Retina.
Conversely, patients on calcium channel blockers were more likely to develop DME.
“Currently, anti-VEGF therapy is recognized as a first-line treatment because of its efficacy in reducing DME and improving vision. Nevertheless, a substantial portion of patients with DME exhibit partial or no response to treatment, and even successful therapy may lack durable efficacy,” Jawad Muayad, a medical student at the